BEGIN ARTICLE PREVIEW:
Over the last few months, much has been learned about how Covid-19 spreads and ways to slow that transmission. Vaccine development is also progressing, but the news that AstraZeneca paused its Covid-19 vaccine trial to investigate the possibility of an adverse reaction is a reminder of the importance of conducting these trials with the utmost care.
Attention is also needed on creating a national strategy to distribute a Covid-19 vaccine. As former state health officers in Massachusetts and Texas, we saw firsthand how the Centers for Disease Control and Prevention led efforts during the H1N1 flu outbreak in 2010-2011 to efficiently distribute a vaccine against it to residents.
That effort taught the CDC, states, and local public health agencies a lot about vaccine distribution. What we learned can help inform a successful national Covid-19 vaccine distribution strategy.
The time to plan is now. Several Covid-19 vaccines are currently under development, but the country can’t wait for a finished product to create a distribution plan. Public health officials will be faced with a mountain of new tasks once distribution begins, and they must take advantage of this time to identify potential problems and develop solutions for an efficient …
END ARTICLE PREVIEW